- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical progress of mRNA vaccines and immunotherapies
Authors
Keywords
-
Journal
NATURE BIOTECHNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-10
DOI
10.1038/s41587-022-01294-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extended interval BNT162b2 vaccination enhances peak antibody generation
- (2022) Helen Parry et al. npj Vaccines
- IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines
- (2022) Siri Tahtinen et al. NATURE IMMUNOLOGY
- Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
- (2021) Eryn Blass et al. Nature Reviews Clinical Oncology
- Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial
- (2021) Cassandra Aldrich et al. VACCINE
- Nanomaterial Delivery Systems for mRNA Vaccines
- (2021) Michael D. Buschmann et al. Vaccines
- Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
- (2021) Kirill V. Kalnin et al. npj Vaccines
- Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
- (2021) István Tombácz et al. MOLECULAR THERAPY
- CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
- (2021) Julian D. Gillmore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- What went wrong with CureVac's mRNA vaccine?
- (2021) Jon Cohen SCIENCE
- Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2
- (2021) Peter G. Kremsner et al. WIENER KLINISCHE WOCHENSCHRIFT
- Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
- (2021) Julia W. Gargano et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The challenge and prospect of mRNA therapeutics landscape
- (2020) Yuhua Weng et al. BIOTECHNOLOGY ADVANCES
- Intratumoral immunotherapy for early stage solid tumors
- (2020) Wan Xing Hong et al. CLINICAL CANCER RESEARCH
- Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
- (2020) Jan Dörrie et al. Pharmaceutics
- Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
- (2020) Abishek Wadhwa et al. Pharmaceutics
- The promise of mRNA vaccines: a biotech and industrial perspective
- (2020) Nicholas A. C. Jackson et al. npj Vaccines
- RNA-based pharmacotherapy for tumors: From bench to clinic and back
- (2020) Xiangping Liang et al. BIOMEDICINE & PHARMACOTHERAPY
- Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
- (2020) Qiang Cheng et al. Nature Nanotechnology
- SARS-CoV-2 infection protects against rechallenge in rhesus macaques
- (2020) Abishek Chandrashekar et al. SCIENCE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site
- (2020) Umesh Kalathiya et al. Journal of Clinical Medicine
- Imidazole‐based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes
- (2020) Xuewei Zhao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term storage of lipid-like nanoparticles for mRNA delivery
- (2020) Pengxuan Zhao et al. Bioactive Materials
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
- (2020) Daniel K. Wells et al. CELL
- Resisting Resistance to Immune Checkpoint Therapy: A Systematic Review
- (2020) Yolla Haibe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune escape: A critical hallmark in solid tumors
- (2020) Keywan Mortezaee LIFE SCIENCES
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging Concepts and Technologies in Vaccine Development
- (2020) Morgan Brisse et al. Frontiers in Immunology
- Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial
- (2020) Vesa Anttila et al. Molecular Therapy-Methods & Clinical Development
- Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche
- (2020) Marvin Krohn-Grimberghe et al. Nature Biomedical Engineering
- Addressing the Cold Reality of mRNA Vaccine Stability
- (2020) Daan J.A. Crommelin et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- (2020) Zijun Wang et al. Science Translational Medicine
- In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
- (2020) N. N. Parayath et al. Nature Communications
- Neo-Antigen mRNA Vaccines
- (2020) Arthur Esprit et al. Vaccines
- Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
- (2019) Asha Kumari Patel et al. ADVANCED MATERIALS
- Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
- (2019) Alexandros Papachristofilou et al. Journal for ImmunoTherapy of Cancer
- RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial
- (2019) Fatma Doener et al. VACCINE
- Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
- (2019) Itishri Sahu et al. MOLECULAR THERAPY
- mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
- (2019) Giulietta Maruggi et al. MOLECULAR THERAPY
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- How mRNA therapeutics are entering the monoclonal antibody field
- (2019) Lien Van Hoecke et al. Journal of Translational Medicine
- A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
- (2019) Martin Sebastian et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity.
- (2019) ANA Maria Arance Fernandez et al. JOURNAL OF CLINICAL ONCOLOGY
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
- (2019) Kimberly J. Hassett et al. Molecular Therapy-Nucleic Acids
- A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
- (2019) Markus Baiersdörfer et al. Molecular Therapy-Nucleic Acids
- Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture
- (2019) Zoltán Kis et al. Biotechnology Journal
- Lipid nanoparticles for delivery of messenger RNA to the back of the eye
- (2019) Siddharth Patel et al. JOURNAL OF CONTROLLED RELEASE
- iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
- (2019) Wesley de Jong et al. Trials
- Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands
- (2019) Melissa P. Lokugamage et al. ADVANCED MATERIALS
- Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
- (2019) Lei Miao et al. NATURE BIOTECHNOLOGY
- Developing neoantigen-targeted T cell–based treatments for solid tumors
- (2019) Tori N. Yamamoto et al. NATURE MEDICINE
- Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
- (2019) F. Zhang et al. Nature Communications
- RAS and BRAF in the foreground for non-small cell lung cancer and colorectal cancer: Similarities and main differences for prognosis and therapies
- (2019) Ioanna Giopanou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
- (2019) Wesley de Jong et al. Trials
- Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
- (2018) Gregory L. Beatty et al. GASTROENTEROLOGY
- The perfect personalized cancer therapy: cancer vaccines against neoantigens
- (2018) Luigi Aurisicchio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates
- (2018) Staci Sabnis et al. MOLECULAR THERAPY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- HIV-Associated Cancers and Related Diseases
- (2018) Robert Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters
- (2018) Colin J. McKinlay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- Phase 1/2 study of mRNA vaccine therapy + durvalumab (durva) ± tremelimumab (treme) in patients with metastatic non-small cell lung cancer (NSCLC).
- (2018) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- New Vaccine Technologies to Combat Outbreak Situations
- (2018) Susanne Rauch et al. Frontiers in Immunology
- Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection
- (2018) Lorna Leal et al. AIDS
- mRNA as novel technology for passive immunotherapy
- (2018) Thomas Schlake et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The establishment of resident memory B cells in the lung requires local antigen encounter
- (2018) S. Rameeza Allie et al. NATURE IMMUNOLOGY
- Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
- (2017) S Guan et al. GENE THERAPY
- Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
- (2017) Darin K. Edwards et al. Journal of Translational Medicine
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
- (2017) Julia Tchou et al. Cancer Immunology Research
- Tools for translation: non-viral materials for therapeutic mRNA delivery
- (2017) Khalid A. Hajj et al. Nature Reviews Materials
- Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
- (2017) Johannes Lutz et al. npj Vaccines
- Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery
- (2016) Owen S. Fenton et al. ADVANCED MATERIALS
- Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
- (2016) Kevin J. Kauffman et al. BIOMATERIALS
- Materials for non-viral intracellular delivery of messenger RNA therapeutics
- (2016) Kevin J. Kauffman et al. JOURNAL OF CONTROLLED RELEASE
- Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression
- (2016) Irene C Turnbull et al. MOLECULAR THERAPY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, andToxoplasma gondiichallenges with a single dose
- (2016) Jasdave S. Chahal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia
- (2016) Joseph F. Nabhan et al. Scientific Reports
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
- (2015) Andreas Thess et al. MOLECULAR THERAPY
- Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
- (2015) Hubert Kübler et al. Journal for ImmunoTherapy of Cancer
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
- (2014) Y. Dong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
- (2014) Kathryn A. Whitehead et al. Nature Communications
- mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
- (2014) Steffen Rausch et al. Human Vaccines & Immunotherapeutics
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
- (2013) Martin A Maier et al. MOLECULAR THERAPY
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
- (2013) M. V. Maus et al. Cancer Immunology Research
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis
- (2010) Julio CC Lorenzi et al. BMC BIOTECHNOLOGY
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
- (2010) Bart R. Anderson et al. NUCLEIC ACIDS RESEARCH
- Lipid-like materials for low-dose, in vivo gene silencing
- (2010) K. T. Love et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
- (2008) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
- (2008) Akin Akinc et al. NATURE BIOTECHNOLOGY
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started